ACPU
EVH icon

Arrowgrass Capital Partners (US)’s Evolent Health EVH Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100,000
Closed -$2.54M – 587
2017
Q2 		$2.54M Buy
+100,000
New +$2.41M 0.02% 455

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s EVH Position: Q3 2017 in Review

Arrowgrass Capital Partners (US) sold out of Evolent Health (EVH) in Q3 2017, closing a stake of 100,000 shares — an estimated $2.54M sold.

Arrowgrass Capital Partners (US) first reported a position in EVH in Q2 2017 and held it in 1 quarter. The position peaked at $2.54M in Q2 2017. 166 funds tracked by Wall St. Rank hold EVH as of Q3 2017.

  • Arrowgrass Capital Partners (US) reported no remaining Evolent Health position as of Q3 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 100,000 Evolent Health shares in Q3 2017, an estimated $2.54M.
  • Arrowgrass Capital Partners (US) first reported a position in Evolent Health in Q2 2017 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Evolent Health position peaked at $2.54M in Q2 2017.
  • 166 funds tracked by Wall St. Rank held Evolent Health as of Q3 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2017, filed 14 Nov 2017.